罗欣药业(002793.SZ)：拟定增募资不超过8.42亿元用于创新药研发项目等

Group 1 - The company, Luoxin Pharmaceutical (002793.SZ), plans to raise a total of no more than RMB 842.40 million through a private placement of shares [1] - The funds raised will be allocated to innovative drug research and development projects, expansion and renovation of raw material drug production facilities, and upgrading of freeze-drying workshops, as well as to supplement working capital [1]